JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2016, Vol. 54 ›› Issue (8): 55-59.doi: 10.6040/j.issn.1671-7554.0.2015.1345

Previous Articles     Next Articles

Effects of perindopril on the expression of plasma miR-423-5p and cardiac function in patients with heart failure

JIANG Yunshan1, TAN Hong2, LI Xiaoyan2, SU Li3, ZHANG Guoming2, ZHANG Hongming2, MENG Nan1   

  1. 1. Base of Postgraduate Education, General Hospital of Jinan Military Command, Jinzhou Medical University, Jinan 250031, Shandong, China;
    2. Department of Cardiology, General Hospital of Jinan Military Command, Jinan 250031, Shandong, China;
    3. Second Department of Cadre, General Hospital of Jinan Military Command, Jinan 250031, Shandong, China
  • Received:2015-12-28 Online:2016-08-10 Published:2016-08-10

PDF (PC)

510

Abstract: Objective To explore the effects of perindopril with different doses on the expression of plasma miR-423-5p in patients with chronic heart failure(CHF)and its correlation with the cardiac function. Methods A total of 75 CHF patients were randomly divided into 3 groups: routine group(n=25, treated with routine medicine), low-dose group(n=25, treated with 4 mg/d perindopril), and high-dose group(n=25, treated with 8 mg/d perindopril). Another 25 healthy controls were enrolled in the control group. After 4 weeks of treatment, pre- and post-treatment levels of LVEDD, LVEF, NT-proBNP, and miR-432-5p of all subjects were measured. Results The baseline level of LVEF of the routine, low-dose and high-dose groups were remarkably lower than that of the control group(P<0.05), while the 山 东 大 学 学 报 (医 学 版)54卷8期 -姜蕴珊,等.培哚普利对慢性心力衰竭患者血浆miR-423-5p的调控及对心功能的影响 \=-baseline levels of LVEDD, NT-proBNP and miR-423-5p of the routine, low-dose and high-dose groups were significantly higher than those of the control group(P<0.05). After 4 weeks of treatment, the level of LVEF of the routine, low-dose and high-dose groups remarkably increased(P<0.05), while the levels of LVEDD, NT-proBNP and miR-423-5p remarkably decreased(P<0.05). After treatment, the LVEF of the low-dose and high-dose groups was significantly higher than that of the routine group(P<0.05), while the LVEDD, NT-proBNP and miR-423-5p levels were significantly lower than those of the routine group(P<0.05). Compared with the low-dose group, the high-dose group had more significant different levels of LVEF, LVEDD, NT-proBNP, and miR-423-5p(P<0.05). Conclusion Perindopril can reduce the plasma miR-423-5p expression in CHF patients, and improve the cardiac function in a dose dependent manner.

Key words: Left ventricular ejection fraction, Heart failure, MicroRNA-423-5p, Perindopril, N-terminal pro-brain natriuretic peptide

CLC Number: 

  • R541.4
[1] Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators[J]. N Engl J Med, 2000, 342(3): 145-153.
[2] Group CM. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators[J]. N Engl J Med, 1991, 325(5): 293-302.
[3] 谈红, 陈瑞敏, 李晓燕, 等. 瑞舒伐他汀对急性冠脉综合征患者CD4+T淋巴细胞miRNA表达的影响[J]. 解放军医学杂志, 2014, 39(2): 99-104. TAN Hong, CHEN Ruimin, LI Xiaoyan, et al. Differences of CD4+T lymphocyte miRNA gene expression in acute coronary artery syndrome(ACS)patients and the effects of rosuvastatin on its expressions[J]. Medical Journal of Chinese Peoples Liberation Army, 2014, 39(2): 99-104.
[4] 李黎, 张丽华, 李凌, 等. 阿托伐他汀对心肌梗死大鼠心室重构和miRNA-21表达的影响[J]. 郑州大学学报(医学版), 2015, 50(4): 488-492. LI Li, ZHANG Lihua, LI Ling, et al. Effect of atorvastatin on ventricular remodeling and expression of miRNA-21 in rats with myocardial infarction[J]. Journal of Zhengzhou University(Medical Sciences), 2015, 50(4): 488-492.
[5] Tijsen AJ, Creemers EE, Moerland PD, et al. MiR423-5p as a circulating biomarker for heart failure[J]. Circ Res, 2010, 106(6): 1035-1039.
[6] Goren Y, Kushnir M, Zafrir B, et al. Serum levels of microRNAs in patients with heart failure[J]. Eur J Heart Fail, 2012, 14(2):147-154.
[7] Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2): 281-297.
[8] Gidlof O, van der Brug M, Ohman J, et al. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression[J]. Blood, 2013, 121(19): 3908-3917.
[9] Besser J, Malan D, Wystub K, et al. MiRNA-1/133a clusters regulate adrenergic control of cardiac repolarization[J]. PLoS One, 2014, 9(11): e113449. doi: 10.1371/journal.pone.0113449.
[10] Neilson JR, Zheng GX, Burge CB, et al. Dynamic regulation of miRNA expression in ordered stages of cellular development[J]. Genes Dev, 2007, 21(5): 578-589.
[11] Topkara VK, Mann DL. Role of microRNAs in cardiac remodeling and heart failure[J]. Cardiovasc Drugs Ther, 2011, 25(2): 171-182.
[12] Thum T, Galuppo P, Wolf C, et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure[J]. Circulation, 2007, 116(3): 258-267.
[13] Fan KL, Zhang HF, Shen J, et al. Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy[J]. Indian Heart J, 2013, 65(1): 12-16.
[14] Dickinson BA, Semus HM, Montgomery RL, et al. Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure[J]. Eur J Heart Fail, 2013, 15(6): 650-659.
[15] 谈红, 李艳敏, 张红明, 等. 慢性充血性心力衰竭患者血浆miR-423-5p和miR-210-3p的表达变化[J]. 临床心血管病杂志, 2014, 30(12): 1081-1085. TAN Hong, LI Yanmin, ZHANG Hongming, et al. The expression changes of plasma miR-423-5p and miR-210-3p in patients with chronic heart failure[J]. Journal of Clinical Cardiology, 2014, 30(12): 1081-1085.
[16] 陈东昌. 慢性心力衰竭患者血清miRNAs及血红素氧合酶-1的变化及意义[D]. 济南:山东大学, 2014.
[17] Song HM, Zhang J, Deng B, et al. Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure[J]. Chinese Medical Journal, 2005, 85(25): 1737-1740.
[18] 谈红, 王雪, 李晓燕, 等. 培哚普利对冠心病患者循环血内皮祖细胞及血管内皮功能的影响[J]. 中国循环杂志, 2015, 30(1): 22-25. TAN Hong, WANG Xue, LI Xiaoyan, et al. Effect of different doses of perindopril on endothelial progenitor cells and vascular endothelial function in patients with coronary artery disease[J]. Chinese Circulation Journal, 2015, 30(1): 22-25.
[1] SHEN Lujia, LU Tianwei, GONG Weiming, ZHAO Yansong, WANG Shukang, YUAN Zhongshang. Application of metabolomic risk score in predicting cardiovascular outcomes in patients with type 2 diabetes mellitus [J]. Journal of Shandong University (Health Sciences), 2025, 63(8): 69-78.
[2] JIA Kui, LI Zhiguo, CHENG Cuiting, LI Zhijuan, LIU Ruiqing. Efficacy and mechanism of ginkgo leaf tablets combined with trimetazidine in the treatment of elderly patients with chronic heart failure [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 19-26.
[3] LI Jing, HAO Panpan. Association between the heart rate variation and the prognosis in patients with acute heart failure at hospital admission and discharge [J]. Journal of Shandong University (Health Sciences), 2025, 63(4): 75-82.
[4] LIU Wenzhao, ZHANG Yuan, MA Xiangping, WEI Fengtao, BU Peili. Correlation between the pre-endothelial activation and stress index and the mortality risk of patients with heart failure [J]. Journal of Shandong University (Health Sciences), 2025, 63(11): 27-35.
[5] DONG Xue, ZHAO Xia, CHENG Zijie, HAN Yi. Pharmacoeconomic evaluation of levosimendan and milrinone in the treatment of 711 patients with severe heart failure complicated with renal injury [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 91-98.
[6] GAO Yan, ZHU Qingying, LUAN Mingya, LIU Kewei. Effects of tolvaptan combined with dapagliflozin on myocardial fibrosis in rats with heart failure [J]. Journal of Shandong University (Health Sciences), 2022, 60(12): 13-18.
[7] FAN Xiaoyan, WANG Yuangeng, CHEN Zetao. Network pharmacologic mechanism of Huangqi Guizhi Wuwu Decoction in treating heart failure [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 70-81.
[8] LAN Hongtao, JIA Xu, TONG Zhoujie, ZHENG Man, HU Boang, ZHONG Ming, ZHANG Wei, WANG Zhihao. Readmission prediction of 152 non-selective adult patients with chronic heart failure [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 63-69.
[9] ZHANG Shuying, WU Xiaofeng, GUO Limin, QIAO Wen, PENG Jieqiong, LI Daqing. Evaluation of two doxorubicin-induced heart failure models and changes of cardiac function [J]. Journal of Shandong University (Health Sciences), 2020, 58(12): 1-7.
[10] MI Chuanxiao, LIU Junni, ZOU Chengwei, ZHOU Nannan. Levels of soluble suppression of tumorigenicity 2 and galectin-3 as predictors of the classification and prognosis of chronic heart failure [J]. Journal of Shandong University (Health Sciences), 2019, 57(1): 62-67.
[11] TAN Hong, MENG Nan, JIN Qun, SU Li, ZHANG Xiaxiao, CHEN Yingjian, HAO Zhe, LIU Xiaohong. Effects of different doses of perindopril on endothelial progenitor cells and systolic cardiac function in rabbits with acute myocardial infarction [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 55-60.
[12] GONG Luwei, ZHOU Lizhen, SU Guohai. Perindopril ameliorates cardiac dysfunction via Akt-FoxO1 pathway in diabetic cardiomyopathy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 65-70.
[13] XU Tianyi, WU Ping, WANG Ailing, CHEN Liping. Clinical effect of milrinone atomization inhalation on treating severe pneumonia complicated with heart failure of neonates and infants [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 88-90.
[14] JIANG Hongmei1,2， CHEN Wenqiang1. Clinical implication of psychotherapy on elderly patients with coronary heart failure undergoing rehabilitation [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(4): 85-88.
[15] CHEN Dong-chang, GU Ying, LU Ke-feng. Changes of serum high sensitivity of troponin T concentration and its clinical significance in chronic heart failure [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(2): 69-72.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd